I really don’t understand your post. AGN spent around 4 million dollars on their phase 1 study. So NYR have 6 million in cash including R&D your 5 times is a 30 million dollar spend on phase 1. Can you please explain where the 30 million dollars came from?
Also please keep it AGN focused as this is the AGN forum
- Forums
- ASX - By Stock
- AGN
- AGN Media thread
AGN Media thread, page-116
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
83.3¢ |
Change
0.023(2.78%) |
Mkt cap ! $105.8M |
Open | High | Low | Value | Volume |
82.5¢ | 86.5¢ | 81.0¢ | $189.7K | 225.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11621 | 82.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
84.5¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5005 | 0.815 |
2 | 25012 | 0.810 |
2 | 13338 | 0.795 |
1 | 7024 | 0.775 |
4 | 23738 | 0.770 |
Price($) | Vol. | No. |
---|---|---|
0.845 | 15000 | 1 |
0.850 | 36000 | 1 |
0.865 | 31981 | 1 |
0.870 | 8000 | 1 |
0.890 | 5000 | 1 |
Last trade - 15.57pm 12/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online